To investigate the alterations in circulating proinflammatory cytokines and cytokine production by peritoneal macrophages during the development of multiple organ dysfunc tion syndrome.
f all patients now dying in the intensive care unit or in a surgical department, 50% to 60% die because of multiple organ dysfunction syndrome. Multiple organ dysfunction syndrome (1 ) is a cumulative sequence of pro gressive deterioration of function oc curring in several organ systems, fre quently seen after shock, in multiple trauma patients suffering from sepsis, severe burn wounds, or pancreatitis (2) (3) (4) (5) (6) (7) . This syndrome generally starts with lung failure and is followed by failure of the liver, gut, and kidneys, organs not necessarily directly in volved in the primary disease. Fur thermore, between the primary dis ease and the development of multiple organ dysfunction syndrome lies a period of days to weeks. Therefore, it is thought that endogenous and exog enous circulating factors mediate this multiple organ dysfunction syndrome (8 , 9) .
Macrophages are multifunctional cells that play a central role in host defense (10, 11) . Not only do they pro cess and present antigens to lympho cytes and exert antimicrobial activi ties, they also act as secretory cells during an inflammatory response, pro ducing a variety of cytokines, such as interleukin (IL)-l, tumor necrosis fac tor (TNF)-a, and IL -6 (10, (12) (13) (14) (15) .
It is assumed that a continuously activated state of the macrophage can result in an abundant production of inflammatory mediators. Such an in flammatory response can occur systemically as a reaction to serious in fections, and may contribute to the development of multiple organ dys function syndrome (16) (17) (18) (19) . It has been suggested that TNF exerts an impor tant role in this respect (20, 21) . How ever, the pathogenic pathways to multiple organ dysfunction syndrome remain to be elucidated. The patterns of cytokines like TNF, IL-1 and IL -6 in the circulation, as well as the capacity of macrophages to produce these sub stances during the development of multiple organ dysfunction syndrome, is not known because of variability in the clinical situation of multiple or gan dysfunction syndrome patients (variety of underlying illness, medica tion), and because tissue macrophages are not easy to obtain in patients.
In our laboratory, an animal model for multiple organ dysfunction syn drome has been developed (9, (22) (23) (24) . Rodents that receive intraperitoneal zymosan display zymosan-induced gen eralized inflammation and develop an illness, which ultimately leads to a clinical picture resembling multiple organ dysfunction syndrome. To gather insight into the possible role of vari ous cytokines in its pathogenesis, we measured the patterns of circulating IL-la and IL-ip, IL-6 , and TNF-a in the subsequent phases of zymosan-induced generalized inflammation in mice. In addition, we investigated the capacity of peritoneal macrophages, harvested in different phases of the model, to produce these cytokines.
MATERIALS AND METHODS

Animals. Experiments were per
formed using inbred C57BL/6 male mice (Charles River, WIGA, Germany), 6 to 8 wks old, weighing 20 to 25 g. The animals had free access to acidi fied water and standard chow (Hope Farms, Woerden, The Netherlands). The day/night cycle was 12/12. Before use, the animals were allowed to ac climatize for 1 wk. Three days before the actual experiment started, the ani mals were customized to daily han dling to reduce stress during the ex periment. The study protocol was approved by the Animal Ethics Re view Committee of the Faculty of Medi cine, University of Nijmegen.
Zymosan-Induced Generalized In flammation. The animal model of zy mosan-induced multiple organ dys function syndrome has been described previously (9, (22) (23) (24) . Mice were given an aseptic intraperitoneal injection with zymosan (Sigma Chemical, St. Louis, MO) suspended at 25 mg/mL, in paraffin oil (60 to 80 milliPascal). The dose was 1 mg/g body weight. Zy mosan A, a carbohydrate-rich cell wall preparation derived from the yeast Saccharomyces cereuisiae was steril ized by y-radiation (5 kiloGray). The particles were suspended in sterile paraffin oil, and high-frequency vibra tion during 1 hr was done to obtain a homogeneous suspension. After sonication, in batches of <6 mL, the sus pension was sterilized again in a waterbath at 100°C for 80 mins. All suspensions were freshly made before use.
Body weight, body temperature, and behavior of the animals injected with the zymosan suspension were moni tored for 12 days. At different time points after the zymosan injection, groups of animals (n = 14, unless oth erwise indicated) were killed to obtain samples of blood, peritoneal cells, and tissues for analysis.
Collection of Plasma and Peritoneal
Cells. Mice were anesthetized with ether and a blood sample was collected individually by means of eye extrac tion in capillary whole blood collectors. K.,-ethylenediaminetetraacetic acidplasma was separated by centrifuga tion at 1500 g for 10 mins at 4°C, pooled (plasma of seven animals was pooled; at each time point, there were two pools available), aliquoted, and stored at -70°C until assayed. Prior experiments showed that pooling of plasma did not affect the outcome of cytokine measurements (unpublished information). After blood collection, the animals were killed by cervical dislo cation, and 5 mL of ice-cold sterile phosphate buffered saline containing 0.38% citrate was injected into the peritoneal cavity. After gently mas saging, the cell suspension was re drawn under aseptic conditions. The cells were washed twice in cold phos phate buffered saline and resuspended in RPMI 1640 (Dutch modification), containing 0.1 M of sodium-pyruvate, 2 mM of L-glutamine (Gibco, Paisley, UK), and 0.05 mg/mL of gentamicin sulfate at a concentration of 1 x 106 viable cells/mL. Cell viability was de termined by trypan blue exclusion.
Cells were plated into a 24-well tis sue culture plate, 1 mL of suspension per well. Both unstim ulated and stimulated (with lipopolysaccharide [10 pg/mL| from Escherichia coli, se rotype 055:B5, Sigma Chemical Com pany) cytokine production was meas ured after a 24-hr incubation at 37°C (5% C 0 2). Cytospin preparations of these cell suspensions were stained w ith Giem sa and M ay-Grunwald (Merck D iagnostica, D arm stad t, Germany).
Cytokine Assays. Plasma concentra tions of the cytokines IL-la, IL-1(3, TNF-a, and IL-6 , and the capacity of peritoneal macrophages to produce these cytokines were determined by assaying the plasma and supernatants of unstimulated and lipopolysaccharide-stimulated cultures. After incu bation of peritoneal cells, the super natants (for measuring IL-lp, TNF-a, and IL-6 ) and cells (for measuring cell associated IL -la ) were collected seperately, aliquoted, and stored at -70°C until assay. Cells were frozen and thawed three times to release the cell-associated cytokine IL-la. IL-la, IL-1(3, and TNF-a were measured by specific radioim m unoassay (RIA). Standards, culture supernatants, cell lysates, and plasma samples were di luted in an RIA-buffer (60 mM Na2HP0,-2H20; 12 mM EDTA; 1 mL sodium-azide [20%]; 2.5 g of bovine serum album in [RIA-grade; Sigma Chemical); 1 mL triton X-100; 25 mL of aprotinin [Bayer, Leverkusen, Ger many] in 1 L of distilled water, pH of 7.4). One hundred microliters of an appropriate rabbit anticytokine-antiserum was added to 100 pL samples and standards and the tubes were kept on ice. After vortexing, the tubes were incubated for 24 hrs at 4°C. Subse quently, 100 pL of the appropriate 125Ilabeled cytokine containing -10,000 counts per minute were added to each tube, and incubation was continued for a further 24 hrs at 4°C. Then, 750 pL of RIA buffer containing 9% (weight/ volume) polyethylene glycol 6000 (Merck Diagnostica, Darmstadt, Ger many), and 3% (volume/volume) goatantirabbit serum was added. The tubes were incubated for 20 mins at room temperature and then centrifugated at 1500 g for 15 mins. Supernatants were discarded carefully and quickly drained on absorbent paper. Remain ing radioactivity was counted in a ycounter. The radioactivity in control tubes (the nonspecific binding activ ity) was subtracted from samples and standards. Detection limits were be tween 0.05 and 0.10 ng/mL. IL -6 ac tivity was determined, using the B9 hybridoma cell proliferation assay. B9 cells were cultured at a density of 5 x 103 cells/well in a microtiter plate, in 200 pL of Iscove's modified Dulbecco's Medium (IMDM) (Gibco, Paisley, UK) supplemented with 40 pg/mL gentami cin sulfate and 10% heat inactivated fetal calf serum, in the presence of either serial dilutions of culture su pernatants or plasma. B9 cell prolif eration was measured by [3H]-Thymidin incorporation (Amersham, UK) during the last 18 hrs of the 72hr incubation. The standard curve ob tained with human recombinant IL-6 was used to determine the bioactivity of IL -6 in the culture supernatants and plasma samples. One unit of IL -6 was the amount required to promote the half maximal growth of the B9 cells. When plasma samples were de termined, 0.38% citrate was added to the culture medium to prevent clot ting. This citrate concentration had no influence on the assay.
Statistical Analysis. The Wilcoxon
test was used to examine differences between cytokine production by cells from control and experimental groups.
For such analyses, p < .05 was consid ered significant. The Mann-Whitney test was used to examine differences between the body weight, body tem perature, and organ weights of control and experimental groups. When this test was used, p < .05 was considered significant.
RESULTS
Intraperitoneal injection with zy mosan resulted in a three-phasic ill ness. During the first phase (days 0 to 2 ), the injection caused an acute peri tonitis, rendering the animals very ill, as was apparent from weight loss, di arrhea, and lethargic behavior. Ap proximately 25% of the animals died during this phase. After 2 days, the animals seemed to recover, demon strated by a gain in body weight and vitality. None of the animals died in this second phase (days 3 to 7). Dur ing the third phase (days 8 to 1 2 ), which started 7 to 8 days after admin istration of zymosan, the animals be came ill again with weight loss, le thargic behavior, hypothermia, and dyspnea, suggesting the onset and de velopment of multiple organ dysfunc tion syndrome. Autopsy of animals on day 12 showed hemorrhagic lungs, en larged spleen and liver, and histo pathologic changes, further indications for multiple organ dysfunction syn drome. Figure 1 shows the changes in body temperature and weight during the three phases of the model, illus trating the course of the illness. Fur ther indications for organ damage or changes were the relative and abso lute organ weights ( Fig. 2 ). There was a significantly (p < .05, Fig. 2A ) in creased relative organ weight of liver, lung, and spleen. Also, the absolute organ weights (p < .05, Fig. 2B ) of the lungs and spleen were significantly increased, while the absolute liver weight was not. Furthermore, there was a significant decrease in absolute kidney weight.
Circulating Cytokines. Within 3 hrs
after injection with zymosan, increased circulating concentrations of TNF-a, as measured by RIA, were detected. These concentrations decreased to nondetectable values within 18 hrs (Fig. 3A ). TNF-a was not detectable again until 8 days after zymosan ad ministration, when it started to in crease again and remained increased until the animals were killed. Analy sis of these samples with the L929 bioassay for TNF showed that the first peak of immunoreactive TNF-a was also biologically active (5.8, 8.7, and 2.0 ng/mL at 3, 6 , and 18 hrs after administration of zymosan, respec tively), while the second immunoreac tive TNF peak measured in the late phase was not (TNF was not detect able at 2, 5, 8 , 10, 11, and 12 days after administration of zymosan). Fig  ure 3B shows the course of IL -6 con centrations in plasma: very high concentrations were found from 3 to 18 hrs after zymosan injection. The concentrations decreased after 1 day, but remained -10 times higher than in the controls throughout the rest of the experiment; concentrations did not increase when TNF increased again. IL-la concentrations in plasma (Fig.  3C) were slightly above the values obtained in control animals (0.16 ng/ mL vs. 0.09 ng/mL, respectively) 3 hrs after zymosan adm inistration, and there was also a slight but transient increase at the beginning of the late phase (0.17 ng/mL at day 7). Circulat ing IL -1 (3 was not detectable at any time.
Cytokine Production By Peritoneal Cells. Cytospin preparations at differ ent phases in the model showed that >95% of the peritoneal cells were macrophages.
Directly after zymosan injection, unstimulated TNF-a production ( Fig.   1198 Crit Care Med 1996 Vol. 24, No. 7
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Time (days) 4) was significantly suppressed com pared with production by cells derived from control animals. Within 8 hrs, the unstimulated production of TNF was back to control values. There was a significant, two-fold increase on day 3 (0.67 vs. 0.36 ng/mL in control, p < .05) in production of TNF compared with control. After that, the values remained significantly increased in this phase, except on day 5. From day 7 onward, the production decreased to control values, and at day 12 the TNF production was significantly decreased (0.17 vs. 0.36 ng/mL in control, p < .05).
Lipopolysaccharide-stimulated pro duction of TNF-a was also suppressed initially but increased significantly within 18 hrs after administration of zymosan (1.56 vs. 0.93 ng/mL in con trol, p < .05; Fig. 4 ). Toward the end of the second phase, there was a four fold increase in stimulated TNF pro duction (4.09 ng/mL on day 6 vs. 0.93 ng/mL in control, p < .001). At the end of this phase and at the beginning of the third phase, there was a transient decrease. However, at all times the concentrations remained significantly increased above those concentrations measured in control animals (e.g., 1.27 ng/mL on day 9 vs. 0.93 ng/mL in the control group, p < .05). Thereafter, the production increased further.
The unstimulated production of IL-6 was significantly suppressed at all phases when compared with control values (p < .01 at all times, Fig. 4 ). Lipopolysaccharide-stimulated IL -6 production was significantly sup pressed in the first phase, but in the second and third phase this produc tion was similar to control values. Figure 5 shows that unstimulated production of IL-la was significantly suppressed (p < .001 at all times) throughout the experiment, except at 6 , 7, and 8 days after administration of zymosan. Lipopolysaccharide-stimu lated production of IL-la was sup pressed significantly at all time points in both the first and the second phase (p < .001 and p < .05, respectively). At the end of the second phase and in the third phase (from day 7 onward), the production levels were again similar to control.
Unstimulated production of IL-1 [3 was transiently but significantly sup pressed directly after administration of zymosan ( Fig. 5 ). During the sec ond phase (days 3 to 7) the production was also suppressed significantly (p < .0 1 ). However, it increased to control values at the beginning of the third phase. Lipopolysaccharide-stimulated production of IL-1 [3 was significantly suppressed the first 6 hrs when com pared with control values. Thereafter, it increased significantly (p < .05 at all time points from day 2 onward) and remained increased throughout the rest of the experiment.
%
DISCUSSION
Zymosan-induced generalized in flammation in the mouse clearly re sults in a triphasic illness. These three phases differ not only in terms of de gree of illness but also in cytokine patterns.
In the first phase of the model, which reflects the shock state, circu lating TNF peaks immediately after zymosan administration. This TNF peak is followed by an increase in cir culating IL -6 concentrations. Produc tion of TNF by peritoneal macrophages (stimulated as well as unstimulated) is significantly suppressed at this time, as is the production of IL-6 . IL-1 f3 is not detectable in the circulation, whereas IL-la is detectable. The find ing of detectable circulating IL-la and nondetectable IL-1(3 seems to be dif ferent from the situation in humans, where IL-1 (3 is the major cytokine released and IL-la is largely cellassociated. The absence of IL-1 (3 in the circulation does not imply that there is no increase in production in the tissues. The fact that the produc tion capacity for IL-1(3 by peritoneal cells is largely preserved during the first phase, could be taken as support for such a suggestion. The cytokine patterns that we ob serve during the first phase partly agree with findings of Ayala and col leagues (25, 26), who found a marked spontaneous release of IL-1, IL-6 , and TNF-a 1 hr after cecal ligation and puncture (CLP). Addition of endotoxin to peritoneal macrophage cultures from CLP mice had no further stimu latory effect. In the zymosan-induced generalized inflammation model, the unstimulated and stimulated IL-la and IL -6 production is suppressed 3 hrs after zymosan administration. IL-1(3 and TNF-a production in our model is virtually unchanged during the first 24 hrs after zymosan administration. This result is in contrast with the find ings of Ayala et al. (26), who found that only TNF-a remained unaltered 4 hrs and 24 hrs after CLP. In the CLP model, the blunting of lipopolysaccharide-inducible cytokine production probably represents the development of a kind of tolerance phenomenon as is also seen during sepsis (27). Our study shows a more disparate cytokine response.
During the second phase, there is no TNF-a detectable in the circula tion, while IL -6 concentrations are supranorm al. Stim ulated and u n stimulated production of TNF-a is sig nificantly increased when compared with production of cells collected from control animals during this phase. The conditions of the macrophages that produce these cytokines in vitro are not necessarily the same as in vivo, but the in vitro conditions represent at least two extreme situations (with or without triggering agent) that could occur within the peritoneal cavity. The total number of cells in the peritoneal cavity 2 days after zymosan adminis tration is ten times higher than in control animals. This increase in cell number means that there is an enor mous production capacity for TNF-a in the peritoneal cavity. Stein and Gordon (28) found that zymosan ad ministration results in a prolonged re lease of TNF, suggesting that the unde graded intracellular zymosan particles cause ongoing release of TNF. Such phenomenon could also happen in vivo, when zymosan is present, although there is no TNF-a detectable in the circulation. Apparently, the animals can handle the excessive TNF-a pro duction capacity during this phase. IL -6 production by peritoneal cells in this phase is significantly decreased (unstimulated) or similar to normal (stimulated). Considering again the ten-fold increase in cells in the perito neal cavity, it seems possible that the slightly increased concentrations found in the circulation merely reflect this increased number of cells.
Circulating IL-la concentrations are increased at the end of the second phase, while unstimulated as well as stimulated production by peritoneal cells is normal at the end of this phase. As for IL-6 , the increased cell number could be responsible for the increase found in the circulation.
Unstimulated production of IL-1 (3 is significantly reduced. However, con sidering the cell number in the perito neal cavity, the total production ca pacity could be much higher than in controls. Stimulated IL-1(3 production is significantly increased. However, circulating concentrations are neither found in these animals, nor in control animals. As in the first phase, the activity of IL-1(3 seems to be confined to the local inflammatory process. The suggestion that the cells develop a kind of tolerance (25) is also not true in this phase of the model.
During the most interesting phase, the third phase, the animals develop the multiple organ dysfunction syn drome. Immunoreactive TNF-a con centrations in the circulation increase again, while the unstimulated produc tion by peritoneal cells decreases be low control values and stimulated pro duction increases significantly above control. IL -6 does not increase to high con centrations again in the circulation but remains at a slightly increased concentration, whereas unstimulated production stays significantly reduced when compared with control values. The TNF-a peak in this phase is not followed by an IL -6 peak as is usually seen. However, it appears that the immunoreactive TNF-a found in the circulation at this time was largely biologically inactive, possibly because of the presence of circulating soluble receptors.
There is considerable lung damage that can be seen macroscopically (hem orrhages, edema) and which is appar ent from the breathing difficulties of the animals. Also, there are foci of inflammation in the liver. Cytokines such as TNF, acting at the tissue level, are responsible for these abnormali ties and thus contribute to the onset and development of multiple organ dysfunction syndrome, as suggested by others (2 0 , 2 1 ) on the basis of data from patient studies.
We do not know to what extent cytokines produced by peritoneal cells contribute to the circulating concen trations and to remote tissue damage. Considering that numbers of cells in the peritoneal cavity are similar to control animals during this phase, other populations of cells probably con tribute to the slightly increased con centrations in the circulation. Further studies are being conducted to eluci date this issue.
Circulating IL -1 (3 concentrations are not detectable, while stimulated production is significantly increased and unstimulated production by peri toneal cells is virtually normal. Ap parently, IL-1[3 is restricted to the cel lular level or scavenged by other proteins.
Circulating IL-la concentrations are similar to control values, whereas unstimulated production is signifi cantly suppressed and stimulated pro duction is similar to control values. These data could imply that the IL-la found in the circulation is generated at a site other than the peritoneal cavity.
he present study shows a complex pattern of circu lating cytokines and produc tion of these cytokines by peritoneal macrophages during the subsequent phases after zymosan administration.
There are various possibilities re garding the contribution of peritoneal cells to circulating cytokine concen trations. It is possible that the cells are in a continuously activated state, due to the persisting zymosan stimu lation. The fact that unstimulated pro duction of all four cytokines is similar to normal or even below normal dur ing the third phase does not necessar ily contradict the role of zymosan as a continuous stimulus, because the pro duction is measured in vitro under circumstances different from those present in vivo (29) . This fact makes it difficult to predict what is actually happening in the peritoneal cavity dur ing different phases in the zymosaninduced generalized inflam m ation model.
The present study shows a complex pattern of circulating cytokines and production of these cytokines by peri toneal macrophages during the subse quent phases after zymosan adminis tration. The peritoneal macrophage is altered in its capacity to produce cytokines after being in contact with zymosan when compared with the nor mal situation. There seem to be differ ential changes in stimulated as well as unstimulated production of the four cytokines studied here, but it seems a differentiated continuous response. Furthermore, the changes in circulat ing cytokines differ in each phase of the model. The contribution of other macrophage populations to these changes needs to be elucidated. In the third phase, when there are foci of inflammation in liver and lungs, the macrophage populations in these tis sues are likely to be altered in their function as well. If these macrophages are triggered to produce cytokines, they too could contribute to the spillover found in the circulation. The TNF-a peak found in this phase is biologically inactive, but the supranormal biologically active IL -6 concen trations are not inactivated or cleared. This inactivation and differential clearing may possibly contribute to, or be a result of, insufficient regula tion of the immune response and may thus lead to multiple organ dysfunc tion syndrome.
These findings seem to confirm our hypothesis that the macrophages are in a continuously activated state, and altered in their function, when the ani mals develop multiple organ dysfunc tion syndrome. Further studies are needed to elucidate what happens with these cytokines at the tissue level, to better understand the pathophysiol ogy of m ultiple organ dysfunction syndrome.
